Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer.

导出 LinkOut

翻译打印收藏纠错

作者： J,Alfred Witjes ^[1] ; Thierry,Lebret ^[2] ; Eva M,Compérat ^[3] ; Nigel C,Cowan ^[4] ; Maria,De Santis ^[5] ; Harman Maxim,Bruins ^[6] ; Virginia,Hernández ^[7] ; Estefania Linares,Espinós ^[8] ; James,Dunn ^[9] ; Mathieu,Rouanne ^[2] ; Yann,Neuzillet ^[2] ; Erik,Veskimäe ^[10] ; Antoine G,van der Heijden ^[6] ; Georgios,Gakis ^[11] ; Maria J,Ribal ^[12]

作者单位： Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: Fred.Witjes@radboudumc.nl. ^[1] Hôpital Foch, Department of Urology, University of Versailles-Saint-Quentin-en-Yvelines, Suresnes, France. ^[2] Department of Pathology, Hôpital La Pitié Salpetrière, UPMC, Paris, France. ^[3] Radiology Department, Queen Alexandra Hospital, Portsmouth, UK. ^[4] University of Warwick, Cancer Research Unit, Coventry, UK; Queen Elizabeth Hospital, Birmingham, UK. ^[5] Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. ^[6] Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain. ^[7] Department of Urology, Hospital Universitario Infanta Sofia, Madrid, Spain. ^[8] Department of Urology, Derriford Hospital, Plymouth, UK. ^[9] Department of Urology, Tampere University Hospital, Tampere, Finland. ^[10] Department of Urology, Eberhard-Karls University, Tübingen, Germany. ^[11] Department of Urology, Hospital Clinic, University of Barcelona, Barcelona, Spain. ^[12]

关键词 Bladder cancer Cystectomy Diagnosis EAU Follow-up Guidelines Metastatic Multimodality Muscle invasive Treatment